Www.crp-sante.lu FLUTCORE project meeting: WP3- Immunogenicity studies I-Na Lu PhD, CRP-Santé Group Leader: Prof. Dr. Claude Muller Institute of Immunology.

Slides:



Advertisements
Similar presentations
In the name of God. Summer School Influenza Unit, Pasteur Institute of Iran summer 2012.
Advertisements

Production and characterization of human anti-V3 monoclonal antibodies from Indian clade C HIV-1 infected patients Raiees Andrabi AIIMS, New Delhi, India.
Langzhou Song VaxInnate Corporation September 26, 2014 A Rationally Designed Form of The TLR5 Agonist, Flagellin, Supports Superior Immunogenicity of Influenza.
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.
TOWARD A UNIVERSAL INFLUENZA VIRUS VACCINE Icahn School of Medicine at Mount Sinai PETER PALESE Department of Microbiology Munich, May 30, 2013.
PANDEMIC INFLUENZA VIRUSES: PAST AND FUTURE PETER PALESE DEPARTMENT OF MICROBIOLOGY MOUNT SINAI SCHOOL OF MEDICINE, NEW YORK ISTANBUL, JULY 11, 2011.
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs RL Stanfield, E Cabezas, AC Satterthwait, EA Stura, AT Profy,
Lab of Immunoregulation
Prof. Fatma Amer Medical Microbiology and Immunology, ZAGAZIG FACULTY OF Medicine, Egypt President of ISC/HWG President of ArAPUA In the Era of Direct.
Class I and II Fusion Proteins To reproduce, enveloped viruses must enter a host cell by fusing their own membrane coat with that of the cell. Fusion is.
The branch that breaks Is called rotten, but Wasn’t there snow on it? Bartolt Brecht Haiti after a hurricane.
LJ-001.  Enveloped and Naked Viruses  Modes of Infection  LJ-001.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
_________________________________________________________________________.
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
Library Creation and TA Cloning for HIV gp120 N88 Mutants Kris Barnes (SUNY Oswego), Piyali Saha (IISc), Raghavan Varadajaran(IISc) Indian Institute of.
4th Year MPharm SRP: Introduction to Pseudotype Viruses
 Hepatitis C virus (HCV) infects 170 million people worldwide  up to 80% of those infected become chronic infection.  HCV infection can cause chronic.
Conclusions Results show that the mutation at the N-linked glycosylation site N276D has a distinct influence on sensitivity to the HJ16 CD4bs neutralizing.
SARS Research Resources at NIAID Linda C. Lambert, Ph.D. Program Officer Influenza, SARS, and Related Viral Respiratory Diseases NIAID/NIH/DHHS.
CCR5 Monoclonal Antibody PRO 140 Inhibited HIV-1 Resistant to Maraviroc, a Small Molecule CCR5 Antagonist Andre J Marozsan Progenics Pharmaceuticals, Inc.
Using Comparative Genomics to Explore the Genetic Code of Influenza Sangeeta Venkatachalam.
110/30/2015 Antigens Antigens Hugh B. Fackrell 210/30/2015 ä Assigned Reading ä Content Outline ä Performance Objectives ä Key terms ä Key Concepts ä.
Steve S.-L. Chen and Woan-Eng Chan Institute of Biomedical Sciences Academia Sinica Taipei, Taiwan R.O.C. August 14, International AIDS Conference.
London, 23 rd September 2015 B cell response and escape mutants Identification of protective hemagglutinin stalk-specific B cell receptor sequences Identification.
The overview…. Complement has three functions: –Opsonin –Chemoattractant –Membrane Attack Complex (MAC) Complement functions in two (three?) systems:
 Structures. Source: Introduction to Protein Structure by Branden & Tooze Up-and-down  barrel.
John R. LaMontagne Memorial Symposium on Pandemic Influenza Research April 4-5, 2005 Institute of Medicine Working Group Five: Immunology, Assay Standardization,
Vaccines: A Molecular View
THE IMMUNE RESPONSES TO VIRUSES
Deborah Spector, Ph.D. Research Interests Association of cytomegalovirus with atherosclerosis Mechanisms governing hearing loss as a result of congenital.
Structure and Function of Large Molecular Assemblies Viral Cell Fusion Erice, June 15, 2006.
Copenhagen, 5 March 2015 Identification of the most immunogenic/protective VLP-HA construct in mice Department of Immunology Development of a universal.
“Neutralizing Antibodies Derived from the B Cells of 1918 Influenza Pandemic Survivors” (Yu et. al) Daniel Greenberg.
Fusion Protein Want to Coat Bacteria with Proteins of Interest Surface Display: Fusions to Membrane Proteins Strept Binding Peptides Histidine Tag Random.
Fusion Proteins and Mechanisms of Action Synaptic vesicle fusion: SNARES and C2 domains Viral Fusion: Class I and Class II Fusion Protiens.
HIV & Influenza Figure 2 | Schematic diagram of HIV‑1 and influenza A virus. Both HIV-1 and influenza A virus are approximately 80–120 nm in diameter and.
Latvian Biomedical Research and Study Centre (BMC), Riga, Latvia.
The Quest for a Universal Flu Vaccine: Headless HA 2.0
The branch that breaks Is called rotten, but Wasn’t there snow on it?
Intracellular Pathogens Extracellular Pathogens
The Body’s Defense Against Pathogens -- Memory
The Major Histocompatibility Complex (MHC)
A Spring-loaded mechanism for the conformational change of Influenza Hemagglutinin Mani Foroohar.
Natalie K. Garcia, Miklos Guttman, Jamie L. Ebner, Kelly K. Lee 
Universal influenza virus vaccines and therapeutic antibodies
Α-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4 by Lucinda Furci, Francesca Sironi, Monica Tolazzi,
Journal Club 19th Feb years ago cis, binding trans, not-binding 1.
Structure of V3-containing HIV-1 gp120 core
Nikolaos G. Papadopoulos, MD, PhD, Spyridon Megremis, PhD, Nikolaos A
Figure 4 The molecular configuration of the CD20 molecule
Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs RL Stanfield, E Cabezas, AC Satterthwait, EA Stura, AT Profy,
The Rational Design of an AIDS Vaccine
Volume 19, Issue 6, Pages (June 2016)
Fig. 6. Epitope mapping of C12G6.
Development of Effective Vaccines against Pandemic Influenza
Comparison of mapped epitopes and peptides identified in immuno-SILAC screening of polyclonal antibodies against trypsin-digested PrESTs. Comparison of.
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
Bispecific Antibodies Against HIV
Volume 46, Issue 4, Pages (April 2017)
Fusion process between the RSV envelope and cellular membrane.
Chimeric HA-based universal influenza virus vaccine concept.
Defining antigen-specific responses with human MHC class II tetramers
Chloe Jones, Isabel Gonzaga, and Nicole Anguiano
Broadening Horizons: New Antibodies Against Influenza
Strategies of CMV envelope protein-mediated immune evasion.
Functional characterization of multidonor class antibodies.
(A) Crystal structure of the hemagglutinin (HA) trimer.
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
Presentation transcript:

FLUTCORE project meeting: WP3- Immunogenicity studies I-Na Lu PhD, CRP-Santé Group Leader: Prof. Dr. Claude Muller Institute of Immunology Centre de Recherche Public de la Santé (CRP-Santé) Europa Royale Hotel, Riga 16th Sep 2014

Outline Headless HA proteins incorporated into VLPs Immunological studies Challenge-protection assays

Outline Headless HA proteins incorporated into VLPs Immunological studies Challenge-protection assays

& Palese, Nat Struct Mol Biol 2009 Influenza virus hemagglutinin (HA)

Comparisons between the features of influenza HA globular head epitopes and HA stalk region epitopes Modified from Ellebedy et al, Front Immunol 2012 Receptor binding domain Viral envelope Globular head region Stalk region

Influenza virus life cycle highlighting the three distinct mechanism of actions of HA stalk-binding Abs Modified from Brandenburg et al, PlosOne 2013

Binding and neutralization mechanism of a mouse HA stalk-specific antibody, C179 Modified from Dreyfus et al, J Virology 2013 C179 inhibits the HA pH-induced conformational change that drives membrane fusion C179 binds multiple group 1 subtypes Exposure to low pH converts HA to a post-fusion state that is sensitive to trypsin digestion Pre-incubation with C179 prevents this conversion, retaining the HA in the protease-resistant

HA (monomer) Headless HA ΔHA stalk HA HA HA HA HA HA HA HA HA HA Schematic of headless HA constructs based on the structure of the HA protein of pH1N1 (A/Luxembourg/46/2009)

ΔHA stalk HA HA HA HA HA HA HA HA HA HA Schematic of headless HA constructs based on the structure of the HA protein of pH1N1 (A/Luxembourg/46/2009) Headless HA In vivo Abs to rHA No Yes (HA2.9) ongoing No ongoing Yes (HA2.3) ongoing No ongoing Good quantity Low quantity

Positions of the HA (HA2.3) epitopes on the structure of the trimeric HA protein of pH1N1 (A/Luxembourg/46/2009)

Positions of the HA (HA2.9) epitopes on the structure of the trimeric HA protein of pH1N1 (A/Luxembourg/46/2009)

Surfaces of the C179-binding, HA & HA epitopes on the structure of the trimeric HA protein C179 binding epitope HA (HA2.3) HA (HA2.9)

HA stalk-specific seroreactivity induced by sublethal dose infection with pH1N1 (A/Luxembourg/46/2009)

Outline Headless HA proteins incorporated into VLPs Immunological studies Challenge-protection assays

(rHA: H1; A/California/07/2009) Seroconversion - ELISA

HA (monomer) HA stalk … Peptide library spanning the HA stalk protein of pH1N1 (A/Luxembourg/46/2009) HA stalk peptide pool (15-mer peptides overlapping by 12 residues)

Positions of the CD4+ T cell epitopes on the structure of the HA protein of H1N1 (A/Luxembourg/46/2009) (N=6 per group)

Antiviral functions of CD4+ T cells Swain et al, Nat Rev Immunol 2012

Flow cytometry profiles of induced CD4+ T cells responses by the HA stalk peptides

* * * * * * * N=6 per group * P<0.5 Functional profile of the memory HA stalk-specific CD4+ T cells responses

Outline Headless HA proteins incorporated into VLPs Immunological studies Challenge-protection assays

Mouse-adapted influenza viruses Bouvier, Viruses 2010 A/Anhui/01/2013 (H7N9) BSL-2 BSL-3

Prof. Dr. Claude P Muller (project supervisor) Sophie Farinelle (animal exp., ELISA, ELISpot) Aliki Papakonstantinou (molecular cloning) Aurélie Sausy (expansion of viruses) Institute of Immunogy, CRP-Santé René Brons (flow cytometry) Core Facility of Flow Cytometry, CRP-Santé Dr. Catherine Leonard (ELISpot, ICS assay) Laboratory of Immunogenetics and Allergology, CRP-Santé Dr. Mike Whelan (project supervisor) Alex Ramirez (animal exp.) Sophie Maucourant (molecular cloning) iQur Ltd Acknowledgment

HA